Stockscreener 앱 받기
3.14
4.85%
-0.16
전일 마감가:
$3.30
열려 있는:
$3.29
하루 거래량:
182.10K
Relative Volume:
0.52
시가총액:
$249.18M
수익:
$351.37M
순이익/손실:
$-174.01M
주가수익비율:
-1.5169
EPS:
-2.07
순현금흐름:
$-126.94M
1주 성능:
-6.82%
1개월 성능:
-10.54%
6개월 성능:
+1.29%
1년 성능:
-14.44%
1일 변동 폭
$3.10
$3.29
1주일 범위
$3.095
$3.38
52주 변동 폭
$2.455
$4.145
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
명칭
Atea Pharmaceuticals Inc
전화
857-204-8109
주소
225 FRANKLIN STREET, BOSTON
AVIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.14 | 249.98M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | 개시 | Evercore ISI | Outperform |
| 2020-11-24 | 개시 | JP Morgan | Overweight |
| 2020-11-24 | 개시 | Morgan Stanley | Overweight |
| 2020-11-24 | 개시 | William Blair | Outperform |
모두보기
Atea Pharmaceuticals Inc 주식(AVIR)의 최신 뉴스
Understanding Atea Pharmaceuticals Inc.’s price movementJuly 2025 Gainers & Weekly High Return Forecasts - Newser
Has Atea Pharmaceuticals Inc. formed a bullish divergence2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Price momentum metrics for Atea Pharmaceuticals Inc. explained2025 Price Action Summary & Low Drawdown Trading Strategies - Newser
Will Atea Pharmaceuticals Inc. continue its uptrend2025 Support & Resistance & Free Safe Capital Growth Stock Tips - Newser
Using AI based signals to follow Atea Pharmaceuticals Inc.July 2025 Sector Moves & Daily Volume Surge Signals - Newser
News impact scoring models applied to Atea Pharmaceuticals Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser
Is Atea Pharmaceuticals Inc. stock bottoming outJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
Published on: 2025-09-12 16:19:18 - Newser
Applying Elliott Wave Theory to Atea Pharmaceuticals Inc.July 2025 Institutional & Intraday High Probability Alerts - Newser
Applying chart zones and confluence areas to Atea Pharmaceuticals Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Short interest data insights for Atea Pharmaceuticals Inc.Earnings Miss & Risk Managed Trade Strategies - Newser
Volatility clustering patterns for Atea Pharmaceuticals Inc.Trade Volume Report & Free Technical Confirmation Trade Alerts - Newser
Will Atea Pharmaceuticals Inc. rebound enough to break evenWeekly Trend Report & Entry Point Strategy Guides - Newser
Should you hold or exit Atea Pharmaceuticals Inc. nowWeekly Earnings Recap & Weekly Top Gainers Trade List - Newser
Published on: 2025-09-11 05:04:19 - Newser
How sentiment analysis helps forecast Atea Pharmaceuticals Inc.Quarterly Risk Review & AI Optimized Trading Strategy Guides - Newser
Multi factor analysis applied to Atea Pharmaceuticals Inc.Weekly Trade Report & Weekly Sector Rotation Insights - Newser
Signal strength of Atea Pharmaceuticals Inc. stock in tech scannersMarket Performance Report & Expert Approved Momentum Trade Ideas - Newser
Intraday pattern recognizer results for Atea Pharmaceuticals Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - Newser
What Fibonacci levels say about Atea Pharmaceuticals Inc. reboundForecast Cut & Technical Pattern Recognition Alerts - Newser
Tick level data insight on Atea Pharmaceuticals Inc. volatilityWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - Newser
Atea Pharmaceuticals, Inc. $AVIR Shares Acquired by MetLife Investment Management LLC - Defense World
What earnings revisions data tells us about Atea Pharmaceuticals Inc.Weekly Trend Recap & Technical Pattern Based Signals - Newser
Will Atea Pharmaceuticals Inc. benefit from macro trends2025 Trading Volume Trends & Long-Term Growth Stock Strategies - Newser
Building trade automation scripts for Atea Pharmaceuticals Inc.2025 Price Targets & Verified Chart Pattern Trade Signals - Newser
What momentum shifts mean for Atea Pharmaceuticals Inc.July 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - Newser
Evaluating Atea Pharmaceuticals Inc. with trendline analysisCPI Data & Proven Capital Preservation Methods - Newser
what’s next for atea pharmaceuticals inc. stock price2025 Buyback Activity & Verified Short-Term Trading Plans - Newser
Atea Pharmaceuticals Inc (AVIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Atea Pharmaceuticals Inc 주식 (AVIR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
0.93%
0.10%
자본화:
|
볼륨(24시간):